Quantum-Si (NASDAQ:QSI) Shares Down 0.8% – Should You Sell?

Quantum-Si Incorporated (NASDAQ:QSI) shares dropped 0.8% during mid-day trading on Monday . The company traded as low as $1.18 and last traded at $1.21. Approximately 4,888,677 shares changed hands during trading, an increase of 1% from the average daily volume of 4,853,345 shares. The stock had previously closed at $1.22.

Analysts Set New Price Targets

Several research firms have recently weighed in on QSI. Canaccord Genuity Group decreased their target price on Quantum-Si from $2.00 to $1.50 and set a “hold” rating for the company in a research report on Monday, December 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $3.60.

Quantum-Si Trading Down 0.8%

The firm has a market cap of $260.74 million, a P/E ratio of -1.81 and a beta of 2.98. The business has a 50-day moving average price of $1.34 and a 200-day moving average price of $1.52.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.17) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.17). Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%. The company had revenue of $0.55 million during the quarter, compared to analyst estimates of $0.60 million. On average, equities analysts anticipate that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Insider Transactions at Quantum-Si

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the company’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total transaction of $30,344.96. Following the completion of the sale, the chief executive officer owned 2,578,018 shares in the company, valued at $3,299,863.04. This represents a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jonathan M. Rothberg sold 26,095 shares of the stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $3.07, for a total value of $80,111.65. Following the sale, the director directly owned 1,904,866 shares in the company, valued at $5,847,938.62. This trade represents a 1.35% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 80,356 shares of company stock valued at $149,566. Company insiders own 22.95% of the company’s stock.

Institutional Trading of Quantum-Si

Hedge funds and other institutional investors have recently made changes to their positions in the business. Prudential Financial Inc. purchased a new position in Quantum-Si during the 2nd quarter worth $25,000. JTC Employer Solutions Trustee Ltd acquired a new stake in Quantum-Si in the second quarter worth about $26,000. Capital Investment Advisory Services LLC boosted its holdings in Quantum-Si by 100.0% in the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after acquiring an additional 10,000 shares in the last quarter. Elite Life Management LLC purchased a new stake in shares of Quantum-Si during the third quarter worth about $29,000. Finally, Cerity Partners LLC acquired a new position in shares of Quantum-Si during the second quarter valued at about $29,000. Hedge funds and other institutional investors own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.